Home > News > BioDelivery Sciences Announces Participation at Conference
April 6th, 2004
BioDelivery Sciences Announces Participation at Conference
Abstract:
BioDelivery Sciences International, Inc. announced today their participation in the NanoBioTech Conference in San Francisco, CA on April 15th & 16th, 2004. Dr. Raphael Mannino, Chief Science Officer of BDSI, will be a guest speaker Friday the 16th. "Nanocochleates are the most advanced oral delivery technology using nanoparticles yet developed for human and animal usage. Uniquely, they are made from all-natural food components consisting of inexpensive soy- phospholipid and calcium. They enable targeted-delivery to specific cell types within the body," said Dr Raphael Mannino.
Source:
biospace
Bookmark:
Nanomedicine
Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013
Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013